Show simple item record

dc.contributor.authorSælen, Marie Grøn
dc.contributor.authorHjelle, Line Veronika
dc.contributor.authorAarsæther, Erling Johan
dc.contributor.authorKnutsen, Tore
dc.contributor.authorAndersen, Sigve
dc.contributor.authorBentzen, Anne Gry
dc.contributor.authorRichardsen, Elin
dc.contributor.authorFosså, Sophie Dorothea
dc.contributor.authorHaugnes, Hege Sagstuen
dc.date.accessioned2023-08-18T12:25:40Z
dc.date.available2023-08-18T12:25:40Z
dc.date.issued2023-06-24
dc.description.abstractTrials reporting adverse health outcomes (AHOs) in terms of patient-reported outcome measures (PROMs) after contemporary curative treatment of prostate cancer (PC) are hampered by study heterogeneity and lack of new treatment techniques. Particularly, the evidence regarding toxicities after radiotherapy (RT) with the volumetric arc therapy (VMAT) technique is limited, and comparisons between men treated with surgery, primary radiotherapy (PRT) and salvage radiotherapy (SRT) are lacking. The aim of the study was to evaluate change in PROMs 3 months after treatment with robotic-assisted laparoscopic prostatectomy (RALP), PRT and SRT administered with VMAT.en_US
dc.identifier.citationSælen, Hjelle, Aarsæther, Knutsen, Andersen, Bentzen, Richardsen, Fosså, Haugnes. Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy. Acta Oncologica. 2023en_US
dc.identifier.cristinIDFRIDAID 2161730
dc.identifier.doi10.1080/0284186X.2023.2224051
dc.identifier.issn0284-186X
dc.identifier.issn1651-226X
dc.identifier.urihttps://hdl.handle.net/10037/30094
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalActa Oncologica
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)en_US
dc.titlePatient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)